光启技术：乐山无人机基地预计明年一季度投产 海翔药业：参投公司创新药中国首款现货型肿瘤治疗性疫苗NWRD08注射液完成Ⅱ期临床首例受试者 入组 【重要事项】 中金公司：每1股东兴证券A股股票可以换得0.4373股中金公司A股股票，每1股信达证券A股股票可以换 得0.5188股中金公司A股股票 信达证券、东兴证券：中金公司拟换股吸收合并东兴证券及信达证券，股票12月18日复牌 北汽蓝谷：未来计划在中高端品牌持续布局L3车型 部分L3车型产品目前正处于开发阶段 兴民智通：通信域控制器目前已在L3、L4无人驾驶汽车Robotaxi、无人物流车上配套 同益中：产品已应用于"神舟五号"到"神舟九号"的海上打捞回收系统 【投资经营】 能科科技：与蓝箭航天合作累计订单额数千万 达华智能：拥有多个卫星操作者的频轨资源 惠丰钻石：拟投10亿建CVD金刚石项目 协创数据：拟投资设立光模块研发和生产建设项目 中科信息：智能麻醉机器人目前顺利完成了十多例的临床试验 长盈精密：目前公司在人形机器人业务上供应给客户的料号超过1000个 博纳影业：储备多部电影和剧集项目，同时参投贺岁档和春节档期多部作品 神工股份：公司硅零部件应用于存储芯 ...

每天三分钟公告很轻松 普路通等多家公司拟重大资产重组；中金公司：披露吸收合并东兴证券、信达证券预案 18日起复牌； 美克家居：筹划收购万德溙控制权 18日起停牌；中国中车：公司及下属企业近期签订合计533.1亿元合 同…… 今日看点 ▼聚焦一：普路通等多家公司拟重大资产重组 普路通：公司拟通过发行股份及支付现金的方式购买CMC等16名交易对方持有的Leqee Group Limited （以下简称"乐其开曼"）100%股份及刘楷、蒋莉莉等6名交易对方持有的乐麦信息技术（杭州）有限公 司（以下简称"杭州乐麦"）8.26%股权，并向智都集团、花都壹号发行股份募集配套资金。截至目前， 本次交易相关的审计、评估及尽职调查工作尚未完成，标的资产交易价格尚未最终确定。本次交易预计 构成重大资产重组。 公告显示，本次交易标的公司是国内领先的全价值链品牌数字及电商服务合作伙伴，服务网络覆盖国内 外多个城市，其业务涵盖电商运营和分销、数字营销、仓储物流及技术解决方案的全链路服务，并拥有 超过30万平方米的仓储物流网络作为支撑。公司表示，本次交易完成后，公司的供应链专业能力能够向 前端延伸，赋能标的公司所服务品牌的库存优化与物流 ...

MACD金叉信号形成，这些股涨势不错！ 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 据统计，12月17日，盘后实朴检测、华凯易佰、中国中冶披露增持情况。包括华谊兄弟、翱捷科技、中 仑新材、大洋生物、三维天地、长盈精密、招标股份、金风科技、天岳先进、盛泰集团、兴业股份在内 的11家A股上市公司披露减持情况。 | | | 12.17上市公司盘后增持情况 | | --- | --- | --- | | 1 | 实检检测 | 高管计划增持800万元-1200万元公司股份 | | 2 | 华凯易值 | 拟回购1500万元-3000万元公司股份 | | 3 | 中国中治 | 拟回购10亿元-20亿元A股股份 | | | | 12.17上市公司盘后减持情况 | | 1 | 华谊兄弟 | 阿里创投及其一致行动人马云的持股比例降至5%以下 | | 2 | 翱捷科技 | 阿里网络完成减持计划 共减持公司总股本的3% | | 3 | 中仑新材 | 股东Strai拟减持不超2%公司股份 | | র্ব | 大洋生物 | 股东汪贤高拟减持不超0.68%股份 | | ട | 三维天地 | 股东拟合计减持不超 ...

Group 1 - Company X plans to invest in the research and production of optical modules, focusing on ultra-low power consumption chips for high-end applications such as AI computing centers [1] - CICC is planning to absorb and merge with Dongxing Securities and Xinda Securities through a share swap, with stock trading resuming on December 18, 2025 [2] - Bona Film Group reports normal operations and has invested in multiple films for the upcoming holiday seasons, including major productions [3] Group 2 - Tongrentang clarifies it does not hold any equity or investment rights in Sichuan Health Pharmaceutical, which is associated with a product mentioned in recent reports [4] - Meike Home is planning to acquire control of Shenzhen Wandeling Technology through a combination of cash and stock issuance, with trading suspended for up to 10 days [5] - Lanhua Ketech has obtained a coal exploration license for a specific area, laying the groundwork for future mining rights [6] Group 3 - China Duty Free Group's subsidiary has signed contracts for duty-free store operations at major Shanghai airports [7] - Baida Group's stock has seen a significant increase of 61.1% in a short period, raising concerns about potential rapid declines [8] - Changyuan Power's subsidiary has successfully connected a new power generation unit to the grid, marking its commercial operation [9] Group 4 - Guangdong Construction has launched two clean energy projects, contributing to a total installed capacity of 5084.52 MW across various energy sources [10] - Shanghai Airport has signed contracts for duty-free store operations, which are expected to positively impact future revenues [11] - Aokeli's subsidiary has entered trial production for a special high-temperature resistant resin project, aligning with its strategic goals in aerospace [12] Group 5 - China Nuclear Engineering has reported cumulative revenue of 92.03 billion yuan as of November 2025 [13] - Zhaobiao Co. plans to reduce its stake by up to 3% through various trading methods [14] - Shengtai Group's major shareholder intends to reduce its stake by up to 3% [15] Group 6 - Xinyi Co. plans to reduce its stake by up to 1% due to personal asset allocation needs [16] - Nanjing Bank intends to fully redeem 49 million preferred shares on December 23, 2025 [17] - Huakai Yibai plans to repurchase shares worth between 15 million and 30 million yuan for employee incentives [18] Group 7 - China Metallurgical Group plans to repurchase A-shares worth between 1 billion and 2 billion yuan [19] - A director of Gao Neng Environment has increased his stake by purchasing 56,100 shares [20] - Jiayuan Technology's shareholders plan to transfer 3.24 million shares, representing 2.51% of the total share capital [21] Group 8 - Pubang Co. has been awarded a construction project for Xiangmi Lake Park with a bid of 333 million yuan [22] - China CRRC has signed contracts totaling approximately 53.31 billion yuan, representing 21.6% of its projected revenue for 2024 [23][24] - Pudong Construction's subsidiaries have won multiple projects totaling 1.649 billion yuan [25] Group 9 - Pingzhi Information's subsidiary has signed a 38.25 million yuan computing service contract with a telecommunications company [26]

Group 1 - CICC is planning to absorb and merge Dongxing Securities and Xinda Securities through a share swap, with trading resuming on December 18, 2025 [1] - Victory Energy's major shareholder plans to transfer 29.99% of its shares to Qiteng Robotics, with no plans for asset restructuring in the next 12 months [2] - China Metallurgical Group intends to repurchase A-shares worth 1 to 2 billion yuan at a price not exceeding 4.9 yuan per share [3] Group 2 - Boten Co. plans to acquire part of the Yifeng Yunding Fund for 1 yuan, with a commitment to fulfill a 20 million yuan capital contribution [4] - Tongyou Technology has initiated a 50 million yuan accounts receivable factoring business [5] - Gaode Infrared has received approval to issue debt financing tools totaling up to 3 billion yuan [6] Group 3 - Zhengyu Industrial's application for a private placement of A-shares has been approved by the Shanghai Stock Exchange [7] - China CRRC signed contracts totaling approximately 53.31 billion yuan, accounting for 21.6% of its projected 2024 revenue [9] - High Energy Environment's director increased his stake by purchasing 56,100 shares [10] Group 4 - Shantou Technology received approval from the CSRC for a convertible bond issuance [11] - Puyang Co. plans to use up to 900 million yuan of idle funds for entrusted wealth management [12] - Huibai New Materials has been awarded a government subsidy of 3.8 million yuan, with the first installment of 2.12 million yuan already received [13] Group 5 - Jiayuan Technology's shareholders plan to transfer 2.51% of the company's shares through a pricing inquiry [14] - Lingpai Technology's subsidiary terminated a 125 million yuan procurement contract due to market changes [15] - Juguang Technology intends to use up to 200 million yuan of idle funds for cash management [16] Group 6 - Zhongwen Media's subsidiary terminated a 200 million yuan private equity fund subscription due to market changes [17] - Zhifei Biological's modified vaccine for monkeypox has received clinical trial acceptance [19] - GeKowei's subsidiary received a government subsidy of 60 million yuan, accounting for 32.12% of the company's audited net profit [20] Group 7 - Wantai Biological's application for a clinical trial of a respiratory syncytial virus vaccine has been accepted [21] - Haitai Technology plans to increase capital in its Thai joint venture from 500,000 to 3 million Thai baht [22] - Shanghai Airport signed contracts for the transfer of duty-free store operating rights [23] Group 8 - Del Shares received approval to issue shares for the acquisition of 100% of Aizhuo Intelligent [24] - Novozymes' products have obtained EU CE IVDR certification [25] - Shibai Testing's chairman's assistant plans to increase shareholding by 8 to 12 million yuan [26] Group 9 - Huitian New Materials plans to invest approximately 97.68 million yuan in a lithium battery anode glue project [27] - Pudong Construction's subsidiaries won contracts totaling 1.649 billion yuan [29] - Acolyte's subsidiary has entered trial production for a special high-temperature resistant resin project [30] Group 10 - Pingzhi Information's subsidiary signed a 38.25 million yuan computing power service contract [31] - Tianma Technology is required to pay 5.3625 million yuan in taxes and penalties [32] - Yahon Pharmaceutical's clinical trial application for GLX002 has been approved [34]

格隆汇12月17日丨实朴检测(301228.SZ)公布，公司董事长特别助理尹炳奎先生基于对公司长期投资价 值的认可，以及对公司未来发展前景的信心，结合对公司股票价值的合理和独立判断，计划自本公告披 露之日起6个月内，以自有资金或自筹资金通过深圳证券交易所系统，采用集中竞价交易或大宗交易方 式增持公司股份，拟增持金额不低于人民币800万元，不高于人民币1,200万元。 ...

每经AI快讯，12月17日，实朴检测(301228.SZ)公告称，公司董事长特别助理尹炳奎基于对公司长期投 资价值及未来发展前景的信心，计划自公告披露之日起6个月内，以自有资金或自筹资金通过深圳证券 交易所系统，采用集中竞价交易或大宗交易方式增持公司股份，拟增持金额不低于800万元，不高于 1200万元。增持价格不设置区间，将根据市场情况择机实施。增持计划可能面临资本市场变化和资金到 位风险。 （文章来源：每日经济新闻） ...

南财智讯12月17日电，实朴检测公告，公司董事长特别助理尹炳奎先生基于对公司长期投资价值的认可 及未来发展前景的信心，计划自本公告披露之日起6个月内，以自有或自筹资金通过深圳证券交易所系 统以集中竞价交易或大宗交易方式增持公司股份，拟增持金额不低于人民币800万元，不高于人民币 1200万元。本次增持不设价格区间，增持主体将根据股价波动及市场趋势择机实施。增持完成后6个月 内不减持，并承诺在增持期间及法定期限内不进行内幕交易、敏感期买卖股份等行为。本次增持不会导 致公司股权分布不具备上市条件，亦不会导致控股股东及实际控制人发生变化。 ...

智通财经APP讯，实朴检测(301228.SZ)发布公告，公司董事长特别助理尹炳奎先生基于对公司长期投资 价值的认可，以及对公司未来发展前景的信心，结合对公司股票价值的合理和独立判断，计划自公告披 露之日起6个月内，以自有资金或自筹资金通过深圳证券交易所系统，采用集中竞价交易或大宗交易方 式增持公司股份，拟增持金额不低于800万元，不高于1200万元。 ...

实朴检测公告，公司董事长特别助理尹炳奎基于对公司长期投资价值认可及未来发展前景信心，计划自 公告披露之日起6个月内，通过深圳证券交易所系统采用集中竞价交易或大宗交易方式增持公司股份， 增持金额不低于800万元且不高于1200万元，增持资金来源为自有或自筹资金。本次增持未设定价格区 间，增持主体将根据股票价格波动情况及资本市场整体趋势择机实施，增持计划实施期限为公告披露之 日起6个月内，增持股份自计划完成之日起6个月内不减持，增持期间及法定期限内承诺不减持公司股 份。 ...